𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Congenital nephrotic syndrome responsive to angiotensin-converting enzyme inhibition

✍ Scribed by Rajasree Sreedharan; Detlef Bockenhauer

Book ID
106159949
Publisher
Springer
Year
2005
Tongue
English
Weight
132 KB
Volume
20
Category
Article
ISSN
0931-041X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Angiotensin-converting enzyme inhibition
Angiotensin-converting enzyme inhibition as a therapeutic principle in Bartter's syndrome
✍ P. Jest; K. E. Pedersen; N. A. Klitgaard; N. Thomsen; K. Kjaer; E. Simonsen πŸ“‚ Article πŸ“… 1991 πŸ› Springer 🌐 English βš– 315 KB

The effect of captopril has been investigated in four patients with Bartter's syndrome treated for 12 weeks. Baseline biochemistry showed normal serum aldosterone (mean 347 pmol.l-1) and a mean serum renin of 217 mU-l-1, and a considerable increase in serum renin during captopril treatment. Serum al

Metabolic effects of long-term angiotens
Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition
✍ R. Reneland; P.-E. Andersson; A. Haenni; H. Lithell πŸ“‚ Article πŸ“… 1994 πŸ› Springer 🌐 English βš– 566 KB

Fifty patients with mild to moderate essential hypertension were randomized to receive either 20 mg fosinopril daily for 16 weeks or placebo for 4 weeks followed by 12 weeks of 50 mg atenolol daily. Prior to these 16 weeks there was a placebo wash-out period of 2-6 weeks. Blood pressure measurements